Calamity club once sponsored by Tyson Fury face being kicked out of league within days as local food bank steps in
The Shrimps face the possibility of being banned from playing their first National League game of the season, which is just three weeks away, after their owners have been unable to pay staff and players.
3
Morecambe are owned by Jason Wittingham's Bong Group Investments, but have been up for sale since 2022.
Financial issues in that time has seen the club slapped with transfer embargoes and impacted on-field performances with Morecambe relegated twice in the last three years.
Now players and staff are seeing their livelihoods impacted as the club have been unable to pay wages.
The club's playing staff were paid just a third of their wages in June and will be able to leave Morecambe for free if they are not paid their next paycheck by Friday.
Financial issues have also meant that school proms, weddings and wakes that were scheduled to be held at their ground, the Mazuma Stadium, have been cancelled.
The dire financial straits have seen a local food bank offer to help employees struggling to make ends meet, while an Indian restaurant fed players for free earlier this month, according to the Guardian.
Fans have even tried to raise funds for the players themselves, generating £362 in a whip-round that was politely refused by the team.
Lifelong fan David Freer, 62, has described the whole ordeal as "soul-destroying" to the Guardian.
3
Fans have been left in the dark as a public war has played out between the club's current owners, their prospective buyers and the board of directors.
The Bond Group had previously announced their intentions to sell the club to London-based investment firm Panjab Warriors - who have since loaned £6million to Morecambe.
However, Panjab Warriors have since accused Bond Group of "deliberately jeopardising the very existence of the club in a last-ditch effort to alter terms that were already agreed".
And things came to a head when Whittingham announced last week that he is selling the club to a mystery third party and not the Panjab Warriors - who had already been ratified by the EFL.
SunSport have contacted Morecambe and the National League for comment.
Labour MP for Morecambe and Lunesdale, Lizzi Collinge, suggested that Whittingham is using the club to leverage his own finances.
Using parliamentary privilege in the Commons last week, she said: "I suspect that Jason Whittingham has built a house of cards, and it is now falling down around his ears.
'Morecambe FC is being held hostage, and it breaks my heart … The likes of Jason Whittingham should never have been allowed to buy a football club.'
Panjab Warriors have also announced that is is considering legal action against the Bond Group for possible "misrepresentation and bad faith dealing'.
The club is on the brink of collapse and could be the latest to fall victim to the gaping holes in rules surrounding football governance.
It all comes just four years after Morecambe were playing at the highest level they ever have in their history in League One.
The Shrimps have even had sponsorship from local fan Tyson Fury in the past.
Former boxing heavyweight champion Fury has even floated the idea of purchasing the club himself in the past.
Speaking to TalkSPORT in 2022, he said: "I'm thinking about buying Morecambe Football Club, they're in League One at the moment.
"So I was thinking I invest X amount of millions in them. Basically throw it at them and keep them going up.
"I've been offered to buy Morecambe Football Club. I own all the training facilities anyway and the training gym. So who knows?
"You might be looking at a football club owner."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Powys County Times
8 minutes ago
- Powys County Times
Euro 2025 final key battles as England seek revenge for Spain's World Cup win
England and Spain will do battle in a second consecutive major final at the European Women's Championship on Sunday. Spain got the better of Sarina Wiegman's side in the World Cup decider two years ago but England will be bidding to retain the trophy they won in 2022. Here, the PA news agency looks at the key contests on the pitch that could decide the match. Alessia Russo v Irene Paredes Spain have not conceded a goal in the knockout stages and have hugely experienced captain Paredes at the centre of their defence. They are undoubtedly a tough nut to crack but Germany showed in the semi-finals that a direct approach can cause them issues. Russo's only goal at the tournament so far came in the big group-stage win over Wales but her workrate and ability to lead the line make her a key player for England whether or not she is on the scoresheet. Paredes will not have fond memories of Russo's pressing in Arsenal's recent Champions League victory against Barcelona. Keira Walsh v Aitana Bonmati The midfield battle is likely to be key to deciding the outcome, and Spain have big hitters in Alexia Putellas and Bonmati, who has won the Ballon d'Or Feminin the last two years. Walsh knows the pair's strengths extremely well having spent two and a half years as team-mates of both at Barcelona. The technical ability of Spain's midfield means it would be a surprise if they do not dominate possession and Walsh may well have to sacrifice her own ball-playing ambitions to a degree to try to be a disruptor and help prevent England's defence coming under too much threat. Leah Williamson v Esther Gonzalez A big concern for Wiegman and England fans will be how shaky the defence has looked at times. While England have managed to dig themselves out of their self-made holes so far, similar generosity against Spain could see them heavily punished. England captain Williamson has a key role to play in marshalling the backline and in trying to blunt the danger of Spain striker Esther Gonzalez. The Gotham FC forward is the tournament's top goalscorer with four, although she has not yet found the net in the knockout stages.
ITV News
8 minutes ago
- ITV News
UK-India trade deal sparks fears over access to cheap medicines for millions
A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...
The Independent
8 minutes ago
- The Independent
Ella Toone confident Sarina Wiegman will get Lionesses their Euro 2025 win
England Women's midfielder Ella Toone has praised manager Sarina Wiegman, expressing confidence in her ability to secure a Euro final win. Toone light-heartedly suggested the team 'nearly killed' Wiegman with their recent late equalising goals. Wiegman has led England to her fifth consecutive major tournament final, where they are set to play against Spain. She is aiming for a hat-trick of European Championship trophies, having previously won with the Netherlands in 2017 and England in 2022. The Euro 2025 final is scheduled to take place on Sunday, 27 July. Watch video above.
